+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antimicrobials Market by Type, Formulation, Origin, End-Use, Distribution Channel - Global Forecast to 2030- Product Image
Antimicrobials Market by Type, Formulation, Origin, End-Use, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Antimicrobials Market by Type, Formulation, Origin, End-Use, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 186 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 6090128
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Antimicrobials Market grew from USD 40.22 billion in 2024 to USD 42.69 billion in 2025. It is expected to continue growing at a CAGR of 6.41%, reaching USD 58.39 billion by 2030.

Understanding the Rising Imperative of Antimicrobial Innovation

The antimicrobial market stands at a critical juncture where scientific innovation intersects with global health imperatives. Rising antimicrobial resistance (AMR) has underscored the urgent need for novel compounds and effective stewardship. Regulatory bodies are implementing more stringent guidelines and accelerated approval pathways, while public and private stakeholders are forging partnerships to fund discovery and expand manufacturing capacities. This dynamic environment demands a nuanced understanding of emerging threats, therapeutic breakthroughs, and evolving policy frameworks.

Against this backdrop, industry leaders, investors, and policymakers require a clear, concise overview of the forces shaping the antimicrobial arena. This executive summary distills complex data and trend analysis into actionable insights, exploring the transformative shifts, tariff impacts, segmentation nuances, regional dynamics, competitive strategies, and targeted recommendations that collectively define the market’s trajectory. By synthesizing the latest developments and expert perspectives, this report equips decision-makers with the strategic intelligence necessary to navigate uncertainties and harness opportunities within the global antimicrobial ecosystem.

Landscape Evolution Driven by Scientific Breakthroughs and Policy Shifts

Over the past decade, advances in genomics, artificial intelligence, and high-throughput screening have redefined the landscape of antimicrobial research. Drug developers are leveraging machine learning models to predict molecular interactions and identify novel scaffolds with potent activity against resistant strains. Concurrently, adoption of green chemistry and continuous manufacturing is enhancing sustainability and cost efficiency. This technological convergence is complemented by a growing emphasis on One Health approaches, which integrate human, animal, and environmental data to curb resistance at its source.

Policy shifts have further accelerated change. Incentive programs offering market entry rewards and transferable exclusivity vouchers have galvanized investment in neglected antibiotic classes. Regulatory agencies are streamlining clinical pathways, promoting regulatory harmonization across borders to reduce duplication and shorten time to market. Meanwhile, public-private partnerships are scaling decentralized production capabilities, ensuring resilience in global supply chains. These converging forces are propelling the antimicrobial sector into a new era of collaborative innovation and robust policy support.

Assessing the 2025 US Tariffs and Their Market Disruption

In 2025, newly implemented United States tariffs on key active pharmaceutical ingredients and finished antimicrobial products are reshaping supply chain economics. Import levies on chemical intermediates sourced from overseas have elevated raw material costs, prompting contract manufacturers to adjust pricing and renegotiate supplier agreements. In response, domestic producers are exploring backward integration to secure raw ingredients and minimize exposure to tariff volatility.

These measures have also influenced global trade flow patterns, driving a realignment of sourcing strategies and fostering regional clustering of manufacturing hubs. Companies are diversifying procurement to mitigate tariff risk, while strategic collaborations with partners in low-cost jurisdictions are gaining prominence. As a result, the tariff landscape is catalyzing a shift toward localized production, increased inventory buffers, and enhanced transparency across the value chain.

Deep Dive into Market Segmentation Reveals Strategic Opportunities

A granular examination of market segments reveals where value creation and competitive tension converge. Based on Type, the market is studied across Anthelminthics, Antibiotics, Antifungals, Antiprotozoals, and Antivirals, with antibiotics maintaining a leading share due to ongoing demand for broad-spectrum agents and novel β-lactam alternatives. Antivirals are gaining momentum amid heightened focus on pandemic preparedness and chronic treatments. Based on Formulation, the market is studied across Inhalable, Injectable, Oral, and Topical presentations, with oral dosage forms dominating volume while injectables drive premium pricing in hospital settings.

Insights into Origin show the market is studied across Natural and Synthetic sources, where synthetic compounds lead innovation in tailored mechanisms of action, and natural extracts underpin growth in agriculture and consumer-grade applications. Based on End-Use, the market is studied across Agriculture, Construction, Consumer Products, Food & Beverage, Healthcare & Medical, Textiles, and Water Treatment, with the Food & Beverage sector further studied across Food Packaging, Food Preservation, and Processing Equipment Sanitation, and the Healthcare & Medical sector further studied across Hospital Surfaces, Medical Devices, Sanitizers & Disinfectants, and Wound Care, while Water Treatment is further studied across Industrial Water Treatment, Municipal Water Treatment, and Wastewater Treatment. Agriculture retains high volume demand, yet healthcare segments command stronger margins and innovation focus. Lastly, based on Distribution Channel, the market is studied across Offline and Online pathways, where digital procurement platforms are redefining traditional reseller relationships and driving consolidation among specialty distributors.

This segmentation framework illuminates strategic inflection points, guiding resource allocation toward high-growth therapeutics, optimized formulations, and emerging end-use applications where regulatory tailwinds converge with unmet needs.

Regional Dynamics Shaping Antimicrobial Deployment Worldwide

Regional dynamics introduce a distinct set of drivers and challenges that shape antimicrobial adoption. In the Americas, robust research infrastructure and well-established regulatory pathways support rapid clinical development, while government incentives bolster antibiotic innovation. Public awareness campaigns and stewardship programs are setting new standards for responsible use. In Europe, Middle East & Africa, regulatory harmonization efforts are balancing market access with stringent safety requirements, even as AMR hotspots demand targeted surveillance and response strategies. Collaborative funding models are emerging to underwrite early-stage projects and bridge market failures.

In Asia-Pacific, accelerating industrialization in key economies is fueling higher demand for antimicrobials in agriculture and water treatment, while expanding middle classes are driving growth in healthcare and consumer hygiene products. Governments are investing in local manufacturing capabilities to reduce import reliance and comply with evolving environmental regulations. Across all regions, supply chain resilience and digital traceability are top priorities, ensuring product quality and mitigating disruptions from geopolitical shifts and logistical bottlenecks.

Competitive Landscape Highlights Proven and Emerging Leaders

The competitive landscape features established pharmaceutical giants, specialized chemical producers, and emerging biotech ventures. Legacy multi-national corporations leverage global distribution networks and deep R&D pipelines to advance late-stage antibiotics and antivirals, while also pursuing strategic collaborations to share risk and accelerate timelines. Niche players are distinguishing themselves through targeted formulations for hospital surfaces and water treatment applications, capturing share in segments where regulatory complexity creates high barriers to entry.

In parallel, innovative start-ups are harnessing novel mechanisms of action, from bacteriophage therapies to quorum-sensing inhibitors, challenging incumbents and attracting venture capital. Consolidation continues as larger organizations acquire specialized firms to broaden their antimicrobial portfolios and strengthen their presence in high-growth end-use markets. The resulting competitive tension fosters rapid evolution, with companies vying on the dimensions of technological differentiation, cost efficiency, and regulatory acumen.

Strategic Imperatives for Industry Leaders to Secure Market Advantage

Industry leaders must prioritize investments in differentiated research and development, focusing on novel compound libraries and accelerated clinical pathways. Strengthening supply chains through strategic partnerships with regional manufacturing hubs will mitigate tariff impacts and logistical risks. Embracing digital platforms for procurement, traceability, and patient adherence monitoring can unlock operational efficiencies and reinforce product stewardship.

Engagement with policymakers and participation in public-private funding consortia will be crucial to shape incentive structures that reward innovation in unmet therapeutic areas. Companies should adopt sustainable production practices, reducing environmental footprints while aligning with tightening regulations across key markets. Finally, aligning commercial strategies to local market dynamics-whether in agriculture applications in Asia-Pacific or hospital-grade solutions in Europe, Middle East & Africa-will ensure targeted resource deployment and maximize market penetration.

Robust Research Methodology Underpins Data-Driven Analysis

This analysis draws on a structured research framework combining primary and secondary methodologies to ensure accuracy and depth. Primary research included in-depth interviews with clinical researchers, regulatory authorities, supply chain experts, and C-level executives spanning pharmaceutical, agricultural, and water treatment sectors. These qualitative insights were triangulated with quantitative data from proprietary transaction databases and published industry reports.

Secondary research encompassed a comprehensive review of peer-reviewed journals, government publications, regulatory filings, and trade association white papers. Data points were validated through cross-referencing and peer review by subject-matter specialists. Segmentation definitions, regional breakdowns, and competitive profiles were refined iteratively to reflect the most current market dynamics and evolving policy landscapes. This rigorous methodology underpins the report’s strategic recommendations and ensures actionable intelligence for stakeholders.

Synthesis of Insights Driving a Resilient Antimicrobial Frontier

Bringing together the key findings, it is clear that scientific innovation, policy evolution, and geopolitical factors are collectively driving a new phase of antimicrobial market evolution. Tariff-induced supply chain realignment has accelerated regionalization, while segmentation analysis highlights high-value opportunities in specialty formulations, targeted end-use applications, and digital distribution channels. Regional insights underscore the importance of market-specific strategies, from incentives in the Americas to manufacturing investments in Asia-Pacific.

Competitive dynamics reveal a dual track of large-scale portfolio expansion by established players and disruptive innovation by agile newcomers. To thrive, organizations must integrate these insights into cohesive strategic plans that prioritize differentiated R&D, resilient supply chains, sustainable practices, and proactive stakeholder engagement. This synthesis equips decision-makers with the clarity and foresight needed to navigate uncertainty and capture value in a rapidly shifting antimicrobial ecosystem.

Market Segmentation & Coverage

This research report categorizes to forecast the revenues and analyze trends in each of the following sub-segmentations:
  • Type
    • Anthelminthics
    • Antibiotics
    • Antifungals
    • Antiprotozoals
    • Antivirals
  • Formulation
    • Inhalable
    • Injectable
    • Oral
    • Topical
  • Origin
    • Natural
    • Synthetic
  • End-Use
    • Agriculture
    • Construction
    • Consumer Products
    • Food & Beverage
      • Food Packaging
      • Food Preservation
      • Processing Equipment Sanitation
    • Healthcare & Medical
      • Hospital Surfaces
      • Medical Devices
      • Sanitizers & Disinfectants
      • Wound Care
    • Textiles
    • Water Treatment
      • Industrial Water Treatment
      • Municipal Water Treatment
      • Wastewater Treatment
  • Distribution Channel
    • Offline
    • Online
This research report categorizes to forecast the revenues and analyze trends in each of the following sub-regions:
  • Americas
    • United States
      • California
      • Texas
      • New York
      • Florida
      • Illinois
      • Pennsylvania
      • Ohio
    • Canada
    • Mexico
    • Brazil
    • Argentina
  • Europe, Middle East & Africa
    • United Kingdom
    • Germany
    • France
    • Russia
    • Italy
    • Spain
    • United Arab Emirates
    • Saudi Arabia
    • South Africa
    • Denmark
    • Netherlands
    • Qatar
    • Finland
    • Sweden
    • Nigeria
    • Egypt
    • Turkey
    • Israel
    • Norway
    • Poland
    • Switzerland
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • Indonesia
    • Thailand
    • Philippines
    • Malaysia
    • Singapore
    • Vietnam
    • Taiwan
This research report categorizes to delves into recent significant developments and analyze trends in each of the following companies:
  • Abbott Laboratories
  • Arxada AG
  • Avient Corporation
  • BASF SE
  • Byotrol Group of Companies
  • Cipla Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Greencraft Labs Private Limited.
  • GSK PLC
  • HeiQ Materials AG
  • ICL Group
  • Locus Fermentation Solutions
  • Merck KGaA
  • Milliken & Company
  • Organisan Corporation
  • Parx Materials NV
  • Pfizer Inc.
  • PURE Bioscience, Inc.
  • RTP Company
  • SANITIZED AG
  • Sciessent LLC
  • Sun Pharmaceutical Industries Ltd
  • The Dow Chemical Company
  • Thermo Fisher Scientific Inc.
  • United-Guardian, Inc.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
3.1. Comprehensive overview of the antimicrobial market's current position its significance and historical evolution shaping its expansion and challenges
3.2. In-depth analysis of consumer preferences product standardization competitive dynamics and regulatory frameworks influencing the antimicrobial market
3.3. Evaluation of the antimicrobial market's current innovation patent landscape competitive advantages and formulation of commercialization strategies
3.4. Comprehensive analysis of the antimicrobial market outlook future growth options emerging technologies and promising opportunities
4. Market Overview
4.1. Introduction
4.1.1. Comprehensive Market Scope and Definition Highlighting Economic Importance Growth Drivers and Innovation Opportunities
4.1.2. In-depth Geographic Overview of Global Antimicrobial Market Trade Dynamics and Regional Performance Influencers
4.1.3. Recent Market Developments Regulatory Changes and Strategic Innovations Impacting the Global Antimicrobial Market
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expansion of antimicrobial use in food packaging to improve shelf life and safety
5.1.1. Expansion of antimicrobial use in food packaging defined by its major characteristics and driving factors
5.1.2. Analysis of market transformation driven by antimicrobial packaging and emerging opportunities
5.1.3. Future trajectory, implications, and strategic considerations for antimicrobial food packaging
5.2. Increasing adoption of antimicrobial coatings and surfaces in healthcare and public spaces
5.2.1. Clear definition and context of increasing antimicrobial coatings and surfaces in healthcare and public spaces
5.2.2. Comprehensive analysis of market impact due to rising adoption of antimicrobial coatings in healthcare and public spaces
5.2.3. In-depth future outlook and implications for antimicrobial coatings adoption in healthcare and public environments
5.3. Growth of natural and plant-based antimicrobials driven by consumer demand for clean-label products
5.3.1. Comprehensive Definition and Contextual Background of the Natural and Plant-Based Antimicrobials Trend
5.3.2. Market Transformation and Expansion Driven by Consumer Demand for Clean-Label Natural Antimicrobials
5.3.3. Future Trajectory, Long-Term Implications and Strategic Considerations for Stakeholders in the Natural Antimicrobials Market
5.4. Impact of rising antibiotic resistance on innovation in antimicrobial solutions and treatment approaches
5.4.1. Understanding the rise of antibiotic resistance and its contextual impact on antimicrobial innovation and treatment strategies
5.4.2. Analyzing the transformative effects of antibiotic resistance on market innovation, demand, and opportunity creation
5.4.3. Projecting the future trajectory of antibiotic resistance and strategic considerations for sustainable antimicrobial innovation
5.5. Regulatory changes influencing the approval and commercialization of new antimicrobial products
5.5.1. Comprehensive understanding of regulatory changes shaping approval and commercialization processes for antimicrobials
5.5.2. In-depth analysis of how evolving regulatory frameworks are accelerating innovation and market opportunities in the antimicrobial sector
5.5.3. Detailed outlook on future regulatory developments and strategic implications for stakeholders in the antimicrobial market
5.6. Advancements in nanotechnology enhancing the effectiveness of antimicrobial agents
5.6.1. Comprehensive understanding of how nanotechnology is advancing antimicrobial agents to enhance effectiveness and application
5.6.2. Expansive market transformations through nanotechnology enhanced antimicrobials enabling innovation and new growth opportunities
5.6.3. Future projections highlighting the implications and strategic advice for stakeholders on nanotechnology advancements in antimicrobials
5.7. Rising investments in research for novel antimicrobial peptides and alternatives to traditional antibiotics
5.7.1. Comprehensive definition and context of rising investments in antimicrobial peptides and alternatives to traditional antibiotics
5.7.2. In-depth analysis of how rising research investments impact the antimicrobial market landscape and business opportunities
5.7.3. Future outlook and strategic implications of rising investments in antimicrobial peptide research
5.8. Integration of antimicrobial technologies in personal care and hygiene products for enhanced protection
5.8.1. Comprehensive definition and contextual background of integrating antimicrobial technologies in personal care products for enhanced protection
5.8.2. Market transformation and new business opportunities driven by integrating antimicrobial technologies in personal care products
5.8.3. Future trajectory, long-term implications, and strategic recommendations for antimicrobial integration in personal care products
5.9. Increasing concerns over antimicrobial resistance prompting development of stewardship programs
5.9.1. Comprehensive explanation of the growing concerns over antimicrobial resistance and stewardship programs
5.9.2. In-depth analysis of the transformative impact of stewardship programs on antimicrobial market opportunities and innovation
5.9.3. Future trajectory, implications, and strategic recommendations related to antimicrobial stewardship programs
5.10. Emerging markets showing rapid growth in antimicrobial product demand due to increasing healthcare awareness
5.10.1. Trend Definition and Context Explaining Emerging Markets Rapid Growth in Antimicrobial Product Demand Due to Healthcare Awareness
5.10.2. Market Impact Detailing How Emerging Markets Growth Drives Innovation and Unlocks New Opportunities in Antimicrobial Products
5.10.3. Future Outlook and Implications for Stakeholders in Emerging Markets' Antimicrobial Demand Surge
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.1.1. Evaluating barriers to entry and the overall threat posed by new entrants in the antimicrobials market
6.1.2. Assessing availability and impact of alternative products as substitutes in antimicrobials
6.1.3. Analyzing supplier influence considering supply chain and material uniqueness in antimicrobials
6.1.4. Examining buyer concentration and preferences shaping market stability and pricing
6.1.5. Analyzing the intensity of competition and strategic positioning in the antimicrobials market
6.2. PESTLE Analysis
6.2.1. Political trends and government policies significantly impacting the antimicrobials market through regulation and stability dynamics
6.2.2. Economic trends such as healthcare spending and inflation directly influencing the affordability and demand for antimicrobials
6.2.3. Changing social attitudes and demographic trends driving demand and ethical considerations in antimicrobial usage
6.2.4. Advances in biotechnology, AI, and diagnostics fostering innovation and precision in antimicrobial development
6.2.5. Strict drug regulations, intellectual property rights, and stewardship laws shaping market entry and compliance costs
6.2.6. Environmental sustainability pressures and regulations driving green innovation and operational resilience in antimicrobials
7. Cumulative Impact of United States Tariffs 2025
7.1. Overview of Major United States Tariffs on Antimicrobial Market From 2023 to 2025 Including Rates and Timelines
7.2. Historical Background of United States Tariff Policies and Economic Rationales from 2018 to 2025 on Developed and Developing Countries
7.3. Analysis of Direct Inflationary Effects of Recent United States Tariff Implementations on the Global Economy
7.4. Examination of Reciprocal Tariffs and Trade Wars Between the United States and Key Global Regions Emphasizing Geopolitical Context
7.5. Evaluation of Economic and Political Consequences of United States Tariffs on Major Trading Partners Including Immediate and Long-Term Effects
7.6. Identification of Long-Term Structural Changes in United States Economy Due to Tariff Policies Including Effects on Consumer Choices and Purchasing Power
7.7. Suggested Policy Responses and Mitigation Strategies to Address Negative Impacts of United States Tariffs on Domestic and International Economies
8. Antimicrobials Market, by Type
8.1. Introduction
8.2. Anthelminthics
8.3. Antibiotics
8.4. Antifungals
8.5. Antiprotozoals
8.6. Antivirals
9. Antimicrobials Market, by Formulation
9.1. Introduction
9.2. Inhalable
9.3. Injectable
9.4. Oral
9.5. Topical
10. Antimicrobials Market, by Origin
10.1. Introduction
10.2. Natural
10.3. Synthetic
11. Antimicrobials Market, by End-Use
11.1. Introduction
11.2. Agriculture
11.3. Construction
11.4. Consumer Products
11.5. Food & Beverage
11.5.1. Food Packaging
11.5.2. Food Preservation
11.5.3. Processing Equipment Sanitation
11.6. Healthcare & Medical
11.6.1. Hospital Surfaces
11.6.2. Medical Devices
11.6.3. Sanitizers & Disinfectants
11.6.4. Wound Care
11.7. Textiles
11.8. Water Treatment
11.8.1. Industrial Water Treatment
11.8.2. Municipal Water Treatment
11.8.3. Wastewater Treatment
12. Antimicrobials Market, by Distribution Channel
12.1. Introduction
12.2. Offline
12.3. Online
13. Americas Antimicrobials Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antimicrobials Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antimicrobials Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.1.1. Comprehensive Analysis of Abbott Laboratories’ Guiding Antimicrobial Products and Their Advantages in the Market
16.3.1.2. Strategic Risk and Vulnerability Assessment for Abbott Laboratories with Focus on Growth Enhancement Opportunities
16.3.2. Arxada AG
16.3.2.1. Detailed Identification and Analysis of Arxada AG's Flagship Products or Services directly addressing the target market needs
16.3.2.2. Comprehensive Analysis of Risks and Vulnerabilities impacting Arxada AG with Actionable Strategies for Growth Enhancement
16.3.3. Avient Corporation
16.3.3.1. Comprehensive overview of Avient Corporation’s strategic position and market establishment in antimicrobial sectors
16.3.3.2. Detailed analysis of Avient Corporation’s flagship antimicrobial products and their alignment with market demands
16.3.3.3. In-depth risk and vulnerability assessment with forward-looking strategies to enhance Avient Corporation’s market standing
16.3.4. BASF SE
16.3.4.1. Comprehensive analysis of BASF SE flagship antimicrobial products emphasizing innovation and market alignment
16.3.4.2. In-depth risk and vulnerability assessment with strategic recommendations for BASF SE’s growth and adaptation in evolving antimicrobial market
16.3.5. Byotrol Group of Companies
16.3.5.1. In-depth Analysis of Byotrol's Flagship Antimicrobial Products and Services that Cater to Target Markets
16.3.5.2. Comprehensive Risk and Vulnerability Assessment for Byotrol with Strategic Growth Recommendations
16.3.6. Cipla Inc.
16.3.6.1. In-depth analysis of Cipla Inc's flagship antimicrobial products and service offerings aligned with market needs
16.3.6.2. Comprehensive risk and vulnerability assessment with actionable strategies to sustain Cipla Inc's growth and innovation in antimicrobial markets
16.3.7. Dr. Reddy’s Laboratories Ltd.
16.3.7.1. A Detailed Examination of Dr. Reddy's Laboratories' Flagship Antimicrobial Products and Services That Define Market Leadership
16.3.7.2. Comprehensive Risk and Vulnerability Analysis with Strategic Recommendations to Enhance Dr. Reddy's Competitive Position and Product Portfolio
16.3.8. Eli Lilly and Company
16.3.8.1. In-depth analysis of Eli Lilly's flagship products and services addressing core market demands with unique advantages
16.3.8.2. Comprehensive evaluation of potential risks and proactive strategies for Eli Lilly to sustain growth and innovation in antimicrobials
16.3.9. F. Hoffmann-La Roche Ltd
16.3.9.1. In-depth analysis of F. Hoffmann-La Roche Ltd's flagship antimicrobial products and their alignment with market needs
16.3.9.2. Comprehensive risk and vulnerability assessment with actionable strategies to strengthen growth and market positioning
16.3.10. Greencraft Labs Private Limited.
16.3.10.1. In-depth analysis of Greencraft Labs flagship antimicrobial products and their market alignment
16.3.10.2. Comprehensive risk and vulnerability assessment alongside strategic growth recommendations for sustaining market leadership
16.3.11. GSK PLC
16.3.11.1. Detailed identification and analysis of GSK PLC's flagship antimicrobial products and services catering to target market needs
16.3.11.2. Thorough analysis of risks and vulnerabilities with strategic recommendations for GSK PLC to enhance market position and product portfolio
16.3.12. HeiQ Materials AG
16.3.12.1. Comprehensive Analysis of HeiQ Materials AG’s Flagship Antimicrobial Products and Market Relevance with Unique Selling Propositions
16.3.12.2. Detailed Risk and Vulnerability Assessment with Strategic Recommendations to Enhance HeiQ Materials AG’s Antimicrobial Market Position and Product Portfolio
16.3.12.3. In-depth Introduction to HeiQ Materials AG’s Strategic Market Positioning and Established Core Strengths in the Antimicrobial Textile Sector
16.3.13. ICL Group
16.3.13.1. In-depth analysis of ICL Group’s flagship antimicrobial products and their unique attributes catering to market needs
16.3.13.2. Comprehensive assessment of potential risks to ICL Group’s growth and strategies to strengthen its antimicrobial portfolio and market stance
16.3.14. Locus Fermentation Solutions
16.3.14.1. Flagship Products and Services with Unique Features and Market Alignment Driving Consumer Value
16.3.14.2. Critical Risk and Vulnerability Analysis with Strategic Enhancements to Strengthen Market Position and Address Emerging Trends
16.3.15. Merck KGaA
16.3.15.1. In-depth identification and analysis of Merck KGaA's flagship antimicrobial products and services catering to key markets
16.3.15.2. Comprehensive risk assessment and actionable strategies to enhance Merck KGaA's antimicrobial product portfolio and market position
16.3.16. Milliken & Company
16.3.16.1. Detailed Analysis of Milliken & Company's Flagship Antimicrobial Products and Their Market Alignment with Consumer Needs
16.3.16.2. Comprehensive Risk and Vulnerability Assessment with Strategic Recommendations for Milliken & Company's Future Growth in Antimicrobials
16.3.17. Organisan Corporation
16.3.17.1. In-depth analysis of the flagship products and services offered by Organisan Corporation that meet consumer needs and distinguish the company from competitors
16.3.17.2. Comprehensive risk and vulnerability assessment for Organisan Corporation along with actionable strategies to enhance growth potential and market position over the upcoming years
16.3.18. Parx Materials NV
16.3.18.1. Thorough Introduction to Parx Materials NV Highlighting Market Position Role and Core Strengths within the Antimicrobial Industry
16.3.18.2. Comprehensive Detailed Analysis of Parx Materials NV’s Flagship Products and Their Market Alignment with Consumer Needs and Industry Expectations
16.3.18.3. In-Depth Risk and Vulnerability Assessment of Parx Materials NV with Strategic Recommendations for Future Growth and Resilience
16.3.19. Pfizer Inc.
16.3.19.1. Comprehensive Overview of Pfizer Inc.s Current Strategic Positioning and Market Establishment in Antimicrobials
16.3.19.2. In-depth Analysis of Pfizer Inc.s Flagship Antimicrobial Products Highlighting Consumer Needs and Unique Selling Propositions
16.3.19.3. Critical Risk and Vulnerability Assessment With Strategic Recommendations to Strengthen Pfizer Inc.s Market Position in Antimicrobials
16.3.20. PURE Bioscience, Inc.
16.3.20.1. In-depth Identification and Analysis of PURE Bioscience’s Flagship Antimicrobial Products and Their Market Alignment
16.3.20.2. Strategic Risk and Vulnerability Assessment Alongside Actionable Recommendations for PURE Bioscience's Growth and Market Sustainability
16.3.21. RTP Company
16.3.21.1. An In-Depth Overview of RTP Company’s Flagship Products and Their Strategic Market Alignment
16.3.21.2. Comprehensive Risk and Vulnerability Assessment with Strategic Recommendations for RTP Company’s Growth and Market Adaptation
16.3.22. SANITIZED AG
16.3.22.1. In-depth analysis of SANITIZED AG's flagship antimicrobial products and services that meet market demands
16.3.22.2. Comprehensive risk and vulnerability assessment of SANITIZED AG with strategies for growth
16.3.23. Sciessent LLC
16.3.23.1. In-depth analysis of the company’s flagship antimicrobial products and their alignment with market needs
16.3.23.2. Comprehensive risk and vulnerability assessment with strategic recommendations for future growth
16.3.24. Sun Pharmaceutical Industries Ltd
16.3.24.1. In-depth analysis of Sun Pharmaceutical’s flagship antimicrobial products and their market alignment
16.3.24.2. Comprehensive risk assessment and actionable strategies to strengthen Sun Pharmaceutical’s market position and product portfolio
16.3.25. The Dow Chemical Company
16.3.25.1. Comprehensive Overview of The Dow Chemical Company's Strategic Role and Market Positioning in Antimicrobials
16.3.25.2. In-Depth Analysis of The Dow Chemical Company's Flagship Antimicrobial Products and Their Market Differentiators
16.3.25.3. Critical Risks Facing The Dow Chemical Company and Strategies to Strengthen Its Antimicrobial Market Leadership and Product Innovation
16.3.26. Thermo Fisher Scientific Inc.
16.3.26.1. In-depth analysis of Thermo Fisher Scientific's flagship antimicrobial products and their market impact
16.3.26.2. Comprehensive risk and vulnerability assessment with actionable strategies for Thermo Fisher Scientific's future growth
16.3.27. United-Guardian, Inc.
16.3.27.1. Flagship Products and Services Delivering Distinctive Benefits in the Antimicrobial Market
16.3.27.2. Comprehensive Risk Assessment with Strategic Recommendations for Growth and Adaptation
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIMICROBIALS MARKET MULTI-CURRENCY
FIGURE 2. ANTIMICROBIALS MARKET MULTI-LANGUAGE
FIGURE 3. ANTIMICROBIALS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIMICROBIALS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIMICROBIALS MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIMICROBIALS MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIMICROBIALS MARKET SIZE, BY END-USE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIMICROBIALS MARKET SIZE, BY END-USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ANTIMICROBIALS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ANTIMICROBIALS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ANTIMICROBIALS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIMICROBIALS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ANTIMICROBIALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ANTHELMINTHICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ANTIFUNGALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ANTIPROTOZOALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIMICROBIALS MARKET SIZE, BY INHALABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ANTIMICROBIALS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ANTIMICROBIALS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ANTIMICROBIALS MARKET SIZE, BY NATURAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIMICROBIALS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIMICROBIALS MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ANTIMICROBIALS MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIMICROBIALS MARKET SIZE, BY CONSUMER PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FOOD PACKAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FOOD PRESERVATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIMICROBIALS MARKET SIZE, BY PROCESSING EQUIPMENT SANITATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ANTIMICROBIALS MARKET SIZE, BY HOSPITAL SURFACES, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIMICROBIALS MARKET SIZE, BY MEDICAL DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ANTIMICROBIALS MARKET SIZE, BY SANITIZERS & DISINFECTANTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIMICROBIALS MARKET SIZE, BY WOUND CARE, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIMICROBIALS MARKET SIZE, BY TEXTILES, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIMICROBIALS MARKET SIZE, BY INDUSTRIAL WATER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ANTIMICROBIALS MARKET SIZE, BY MUNICIPAL WATER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIMICROBIALS MARKET SIZE, BY WASTEWATER TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL ANTIMICROBIALS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIMICROBIALS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES ANTIMICROBIALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 62. CANADA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. CANADA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 64. CANADA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 65. CANADA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 66. CANADA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 67. CANADA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 68. CANADA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 69. CANADA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 73. MEXICO ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 76. MEXICO ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 77. MEXICO ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. GERMANY ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. GERMANY ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 113. GERMANY ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 114. GERMANY ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 116. GERMANY ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 117. GERMANY ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 118. GERMANY ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 122. FRANCE ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 125. FRANCE ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 126. FRANCE ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 130. RUSSIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 131. RUSSIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. ITALY ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. ITALY ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 137. ITALY ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 138. ITALY ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 139. ITALY ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 140. ITALY ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 141. ITALY ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 142. ITALY ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 143. SPAIN ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 144. SPAIN ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 145. SPAIN ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 146. SPAIN ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 147. SPAIN ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 148. SPAIN ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 149. SPAIN ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 150. SPAIN ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 154. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 155. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 156. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 157. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 158. UNITED ARAB EMIRATES ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 162. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 163. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 164. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 165. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 166. SAUDI ARABIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 170. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 171. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 172. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 173. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 174. SOUTH AFRICA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 175. DENMARK ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 176. DENMARK ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 177. DENMARK ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 178. DENMARK ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 179. DENMARK ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 180. DENMARK ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 181. DENMARK ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 182. DENMARK ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 186. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 187. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 188. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 189. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 190. NETHERLANDS ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. QATAR ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 192. QATAR ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 193. QATAR ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 194. QATAR ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 195. QATAR ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 196. QATAR ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 197. QATAR ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 198. QATAR ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 199. FINLAND ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 200. FINLAND ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 201. FINLAND ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 202. FINLAND ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 203. FINLAND ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 204. FINLAND ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 205. FINLAND ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 206. FINLAND ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 210. SWEDEN ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 218. NIGERIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 219. NIGERIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 220. NIGERIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 221. NIGERIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 222. NIGERIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 223. EGYPT ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 224. EGYPT ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 225. EGYPT ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 226. EGYPT ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 227. EGYPT ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 228. EGYPT ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 229. EGYPT ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 230. EGYPT ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 231. TURKEY ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 232. TURKEY ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 233. TURKEY ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 234. TURKEY ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 235. TURKEY ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 236. TURKEY ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 237. TURKEY ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 238. TURKEY ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 242. ISRAEL ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 243. ISRAEL ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 244. ISRAEL ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 245. ISRAEL ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 246. ISRAEL ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 247. NORWAY ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 248. NORWAY ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 249. NORWAY ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 250. NORWAY ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 251. NORWAY ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 252. NORWAY ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 253. NORWAY ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 254. NORWAY ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 255. POLAND ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 256. POLAND ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 257. POLAND ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 258. POLAND ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 259. POLAND ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 260. POLAND ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 261. POLAND ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 262. POLAND ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 269. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 270. SWITZERLAND ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 275. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 276. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 277. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 278. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 279. ASIA-PACIFIC ANTIMICROBIALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 280. CHINA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 281. CHINA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 282. CHINA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 283. CHINA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 284. CHINA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 285. CHINA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 286. CHINA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 287. CHINA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 288. INDIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 289. INDIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 290. INDIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 291. INDIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 292. INDIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 293. INDIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 294. INDIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 295. INDIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 296. JAPAN ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 297. JAPAN ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 298. JAPAN ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 299. JAPAN ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 300. JAPAN ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 301. JAPAN ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 302. JAPAN ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 303. JAPAN ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 307. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 308. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 309. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 310. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 311. AUSTRALIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 315. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 316. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 317. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 318. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 319. SOUTH KOREA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 323. INDONESIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 324. INDONESIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 325. INDONESIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 326. INDONESIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 327. INDONESIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 328. THAILAND ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 329. THAILAND ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 330. THAILAND ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 331. THAILAND ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 332. THAILAND ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 333. THAILAND ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 334. THAILAND ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 335. THAILAND ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 336. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 337. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 338. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 339. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 340. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 341. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 342. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 343. PHILIPPINES ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 344. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 345. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 346. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 347. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 348. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 349. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 350. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 351. MALAYSIA ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 352. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 353. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 354. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 355. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 356. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD MILLION)
TABLE 357. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY HEALTHCARE & MEDICAL, 2018-2030 (USD MILLION)
TABLE 358. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY WATER TREATMENT, 2018-2030 (USD MILLION)
TABLE 359. SINGAPORE ANTIMICROBIALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 360. VIETNAM ANTIMICROBIALS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 361. VIETNAM ANTIMICROBIALS MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
TABLE 362. VIETNAM ANTIMICROBIALS MARKET SIZE, BY ORIGIN, 2018-2030 (USD MILLION)
TABLE 363. VIETNAM ANTIMICROBIALS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
TABLE 364. VIETNAM ANTIMICROBIALS MARKET SIZE, BY FOOD & BEVERAGE, 2018-2030 (USD

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antimicrobials market report include:
  • Abbott Laboratories
  • Arxada AG
  • Avient Corporation
  • BASF SE
  • Byotrol Group of Companies
  • Cipla Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • Greencraft Labs Private Limited.
  • GSK PLC
  • HeiQ Materials AG
  • ICL Group
  • Locus Fermentation Solutions
  • Merck KGaA
  • Milliken & Company
  • Organisan Corporation
  • Parx Materials NV
  • Pfizer Inc.
  • PURE Bioscience, Inc.
  • RTP Company
  • SANITIZED AG
  • Sciessent LLC
  • Sun Pharmaceutical Industries Ltd
  • The Dow Chemical Company
  • Thermo Fisher Scientific Inc.
  • United-Guardian, Inc.

Table Information

Report AttributeDetails
No. of Pages186
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 42.69 Billion
Forecasted Market Value ( USD ) by 2030 $ 58.39 Billion
Compound Annual Growth Rate6.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Green Antimicrobial Market by Type, Source, Form, Distribution Channel, End-Use - Global Forecast to 2030 - Product Image

Green Antimicrobial Market by Type, Source, Form, Distribution Channel, End-Use - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Antimicrobial Ingredients Market by Application, Type, Form, Function, Source - Global Forecast to 2030 - Product Image

Antimicrobial Ingredients Market by Application, Type, Form, Function, Source - Global Forecast to 2030

  • Report
  • 198 Pages
  • Global
From
Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report by Technology (Microbiology Culture, PCR), End-use (Hospitals, Diagnostic Laboratories), Pathogen, Region, and Segment Forecasts, 2025-2030 - Product Image

Antimicrobial Resistance Diagnostics Market Size, Share & Trends Analysis Report by Technology (Microbiology Culture, PCR), End-use (Hospitals, Diagnostic Laboratories), Pathogen, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report by Animal Type (Production, Companion), Product (Accessories & Consumables, Automated AST Instruments), End-use, Region, and Segment Forecasts, 2024-2030 - Product Image

Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Trends Analysis Report by Animal Type (Production, Companion), Product (Accessories & Consumables, Automated AST Instruments), End-use, Region, and Segment Forecasts, 2024-2030

  • Report
  • 180 Pages
  • Global
From
Polymer Antimicrobial Additives Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Polymer Antimicrobial Additives Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 89 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.